11)
LPS is a major inflammatory molecule that triggers the production of pro-inflammatory toxins, cytokines such as TNF-a and IL-1b in various cell types. 12, 13) TNF-a plays a key role in the induction and perpetuation of inflammation in autoimmune reactions, and it also activates T cells and macrophages and up-regulates other pro-inflammatory cytokines and endothelial adhesion molecules, such as intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1), which enhance the recruitment of leukocytes to sites of inflammation. 14) On the other hand, IL-1b is one of the most important inflammatory cytokines secreted by macrophages. During inflammation, increased IL-1b release leads to cell or tissue damage, 15, 16) alternatively, a reduction in IL-1b release from macrophages may slow down inflammatory responses to LPS stimulation.
Nuclear transcription factor kappa-B (NF-kB) is one of the most ubiquitous transcription factors, and regulates the expressions of genes involved in cellular proliferation, inflammatory responses and cell adhesion. The activation of NF-kB induces the transcription of multiple pro-inflammatory mediators including iNOS, COX-2, TNF-a, IL-1b, and others. 17, 18) Active NF-kB exists mainly as a heterodimer that consists of subunits of the Rel family p50 and p65, which is normally sequestered in the cytosol as an inactive complex by binding to inhibitors of kB (IkBs) in unstimulated cells. 19) The mechanism of NF-kB activation involves the phosphorylation of IkBs at two critical serine residues (Ser 32 and Ser
36
) via the IkB kinase (IKK) signalosome complex. [20] [21] [22] Once IkBs are phosphorylated, they are ubiquitinated and degraded by 26S proteosome. 23) The resulting free NF-kB is then translocated into the nucleus, where it binds to kB binding sites in the promoter region of target genes, and induces the transcription of pro-inflammatory mediators. 24) Thus, as a part of our on-going screening program to evaluate the anti-inflammatory potentials of natural compounds, we investigated the in vitro anti-inflammatory activities of constituents isolated from the stem barks of S. japonica. 25) Previous phytochemical studies performed on this plant have resulted in the isolation of jegosaponins and benzofurans. [26] [27] [28] [29] Jegosaponins from fresh fruits display antisweet activity, 25) and egonol from seeds has attracted the attention of synthetic organic chemists, due to its activity against human leukemic HL-60 cells. 30, 31) Although styraxoside B, egonol, masutakeside, and styraxlignolide A have been reported to play a role in the enhancement of anti-complement activity, 32) no report has been issued on its anti-inflammatory activity or mode of action. Therefore, we evaluated and compared the effects of various terpenes and lignans ( Fig. 1) isolated from the stem bark of S. japonica on LPS-induced NO and PGE 2 production via NF-kB binding in RAW 264.7 macrophage cells.
MATERIALS AND METHODS
Materials Styraxoside A, styraxoside B, egonol, masutakeside I and styraxlignolide A previously isolated from the stem bark of Styrax japonica SIEB. et ZUCC were used. 32) These compounds isolated were determined by HPLC to be Ͼ97% pure. Dulbecco's modified Eagle's minimum essential medium (DMEM), fetal bovine serum (FBS), penicillin, and streptomycin were obtained from Life Technologies Inc. (Grand Island, NY, U.S.A.). iNOS, COX-2 and b-actin monoclonal antibodies and the peroxidase-conjugated secondary antibody were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, U.S.A.). The enzyme immunoassay (EIA) kit for prostaglandin E 2 (PGE 2 ), tumor necrosis factora (TNF-a) and interleukin-1b (IL-1b) were obtained from R&D Systems (Minneapolis, MN, U.S.A.). iNOS, COX-2, TNF-a, IL-1b and b-actin oligonucleotide primers were purchased from Bioneer (Seoul, Korea). Cell Culture and Sample Treatment The RAW 264.7 macrophage cell line was obtained from the Korea Cell Line Bank (Seoul, Korea). These cells were grown at 37°C in DMEM medium supplemented with 10% FBS, penicillin (100 units/ml), and streptomycin sulfate (100 mg/ml) in a humidified atmosphere of 5% CO 2 . Cells were incubated with the tested samples at increasing concentrations (50, 100, 200 mM) or positive chemical and stimulated with LPS 1 mg/ml for the indicated time. Tested samples dissolved in DMSO were added to the medium in serial dilution (the final DMSO concentration in all assays did not exceed 0.05%).
MTT Assay for Cell Viability Cytotoxicity studies after 24 h of continuous exposure to the various concentration of tested samples were measured with a colorimetric assay based on the ability of mitochondria in viable cells to reduce MTT as described previously. 33) Nitrite Determination The nitrite accumulated in culture medium was measured as an indicator of NO production based on the Griess reaction. Briefly, 100 ml of cell culture medium was mixed with 100 ml of Griess reagent [equal volumes of 1% (w/v) sulfanilamide in 5% (v/v) phosphoric acid and 0.1% (w/v) naphtylethylenediamine-HCl], incubated at room temperature for 10 min, and then the absorbance at 540 nm was measured in a microplate reader (Perkin Elmer Cetus, Foster City, CA, U.S.A.). Fresh culture medium was used as the blank in all experiments. The amount of nitrite in the samples was measured with the sodium nitrite serial dilution standard curve and nitrite production was measured. PGE 2 , TNF-a a and IL-1b b Assay PGE 2 , TNF-a and IL1b levels in macrophage culture medium were quantified by EIA kits according to the manufacturer's instructions.
Western Blot Analysis Cellular proteins were extracted from control and styraxoside A-treated RAW 264.7 cells. Cells were collected by centrifugation and washed once with phosphate-buffered saline (PBS). The washed cell pellets were resuspended in extraction lysis buffer (50 mM HEPES pH 7.0, 250 mM NaCl, 5 mM EDTA, 0.1% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride, 0.5 mM dithiothreitol, 5 mM Na fluoride and 0.5 mM Na orthovanadate) containing 5 mg/ml each of leupeptin and aprotinin and incubated with 20 min at 4°C. Cell debris was removed by microcentrifugation, followed by quick freezing of the supernatants. The protein concentration was determined using the Bio-Rad protein assay reagent according to the manufacture's instruction. Forty micrograms of cellular protein from treated and untreated cell extracts was electroblotted onto a nitrocellulose membrane following separation on a 10% SDS-polyacrylamide gel electrophoresis. The immunoblot was incubated overnight with blocking solution (5% skim milk) at 4°C, followed by incubation for 4 h with a 1 : 500 dilution of monoclonal anti-iNOS, 1 : 1000 dilution of anti-COX-2 antibody and b-actin antibody (Santa Cruz Biotechnology Inc.). Blots were washed four times with Tween 20/Tris-buffered saline (TTBS) and incubated with a 1 : 1000 dilution of horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology Inc.) for 1 h at room temperature. Blots were again washed three times with and then developed by enhanced chemiluminescence (Amersham Life Science, Ar- [12] [13] [14] [15] [16] [17] [18] ) 0.5 mg/ml. Then PCR analyses were performed on the aliquots of the cDNA preparations to detect iNOS, COX-2, TNF-a, IL-1b and b-actin (as an internal standard) gene expression using a thermal cycler (Perkin Elmer Cetus, Foster City, CA, U.S.A.). The reactions were carried out in a volume of 25 ml containing (final concentration) 1 units of Taq DNA polymerase, 0.2 mM dNTP, ϫ10 reaction buffer, and 100 pmol of 5Ј and 3Ј primers. After initial denaturation for 2 min at 95°C, thirty amplification cycles were performed for iNOS (1 min of 95°C denaturation, 1 min of 60°C annealing, and 1.5 min 72°C extension), COX-2 (1 min of 94°C denaturation, 1 min of 60°C annealing, and 1 min 72°C extension), TNF-a (1 min of 95°C denaturation, 1 min of 55°C annealing, and 1 min 72°C extension) and IL-1b (1 min of 94°C denaturation, 1 min of 60°C annealing, and 1 min 72°C extension). PCR primers used in this study are listed below and were purchased from Bioneer (Seoul, Korea): sense strand iNOS, 5Ј-AAT GGC AAC ATC AGGTCG GCC ATC ACT-3Ј, anti-sense strand iNOS, 5Ј-GCT GTG TGT CAC AGA AGT CTC GAACTC-3Ј; sense strand COX-2, 5Ј-GGA GAG ACT ATC AAG ATA GT-3Ј anti-sense strand COX-2, 5Ј-ATG GTC AGT AGA CTT TTA CA-3Ј; sense strand TNF-a, 5Ј-ATG AGC ACA GAA AGC ATGATC-3Ј, anti-sense strand TNF-a, 5Ј-TAC AGG CTT GTC ACT CGA ATT-3Ј; sense strand IL-1b, 5Ј-TGC AGA GTT CCC CAA CTG GTA CAT C-3Ј; anti-sense strand IL1b, 5Ј-GTG CTG CCTAAT GTC CCC TTG AAT C-3Ј; sense strand b-actin, 5Ј-TCA TGA AGT GTG ACG TTG ACATCC GT-3Ј, anti-sense strand b-actin, 5Ј-CCT AGA AGC ATT TGC GGT GCA CGA TG-3Ј. After amplification, portions of the PCR reactions were electrophoresed on 2% agarose gel and visualized by ethidium bromide staining and UV irradiation.
Nuclear Extraction and Electrophoretic Mobility Shift Assay (EMSA) RAW 264.7 macrophages cells were plated in 100-mm dishes (1ϫ10 6 cells/ml). The cells were treated with various styraxoside A concentrations (50, 100, 200 mM), stimulated with LPS for 1 h, washed once with PBS, scraped into 1 ml of cold PBS, and pelleted by centrifugation. Nuclear extracts were prepared as described previously with slight modification. The cell pellet was resuspended in hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.2 mM PMSF, 0.5 mM DTT, 10 mg/ml aprotinin) and incubated on ice for 15 min. Then the cells were lysed by the addition of 0.1% Nonidet P-40 and vigorous vortexing for 10 s. The nuclei were pelleted by centrifugation at 12000ϫg for 1 min at 4°C and resuspended in high salt buffer (20 mM HEPES, pH 7.9, 25% glycerol, 400 mM KCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 1 mM NaF, 1 mM sodium orthovanadate). Nuclear extract 10 mg was mixed with the double-stranded NF-kB oligonucleotide. 5Ј-AGTTGAGGGGACTTTCCCAGGC-3Ј end-labeled by [g-32 P] dATP (underlying indicates a kB consensus sequence or a binding site for NF-kB/cRel homodimeric and heterodimeric complex). Binding reactions were performed at 37°C for 30 min in 30 ml of reaction buffer containing 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA, 4% glycerol, 1 mg of poly (dI-dC), and 1 mM DTT. The specificity of binding was examined by competition with the 80-fold unlabeled oligonucleotide. DNA and protein complexes were separated from the unbound DNA probe on native 5% polyacrylamide gels at 100 V in 0.5ϫTBE buffer. The gels were vacuum dried for 1 h at 80°C and exposed to X-ray film at Ϫ70°C for 24 h.
Statistical Analysis Results are expressed as meanϮ S.D. of at least three experiments performed using different cell preparations in vitro. Statistically significant values were compared using a non-parametric multiple comparisons test (Kruskal-Wallis test) followed by Dunn's test. Statistical significance was set at pϽ0.05.
RESULTS

Effects of Terpenes and Lignans Isolated from the Stem Bark of S. japonica on LPS-Induced NO and PGE 2 Production
To assess the effects of styraxoside A, styraxoside B, egonol, masutakeside I and styraxlignolide A on LPS-induced NO production in RAW 264.7 cells, cells were treated with LPS (1 mg/ml) for 24 h after treatment for 1 h with/without these agents. Neither LPS nor samples were added to the control (Con) group. Cell culture media were harvested post-treatment and NO levels were quantified using the Griess reaction. Styraxoside A (IC 50 ϭ137.6 mM) was found to have the most potent effect on NO accumulation inhibition ( Fig. 2A) . L-NIL (10 mM) was used as a positive NO production inhibitor in this study. To determine whether styraxoside A, styraxoside B, egonol, masutakeside I and styraxlignolide A inhibit PGE 2 production, cells were pre-incubated with each compound for 1 h and then activated with 1 mg/ml of LPS for 24 h. As shown in Fig. 2B , styraxoside A also significantly inhibited the production of PGE 2 , with an IC 50 value of 47.9 mM. The cytotoxic effects of these five compounds were also evaluated in the absence or presence of LPS, and only egonol was found to affect cell viability at the concentrations used (50, 100, 200 mM) and to inhibit NO and PGE 2 inhibitions (data not shown). Thus, the inhibitory effects of styraxoside A were not attributable to any cytotoxic effect.
Effects of Styraxoside A on LPS-Induced TNF-a a and IL-1b b Production and their mRNA Expressions
Since styraxoside A was found to most potently inhibit the pro-inflammatory mediators, we further investigated its effects on LPS-induced TNF-a and IL-1b release by enzyme immunoassay and RT-PCR. It was found that pretreating cells with styraxoside A reduced LPS-induced TNF-a and IL-1b production (Figs. 3A, B) and their mRNA expressions (Fig.  3C ) in a concentration-dependent manner.
Effects of Styraxoside A on LPS-Induced iNOS and COX-2 Protein and mRNA Expressions
To determine the relationships between the inflammatory mediators NO and PGE 2 and the modulation of the expressions of iNOS and COX-2, we examined their expression levels by Western blot. In response to LPS, the expression of iNOS was markedly upregulated, and styraxoside A significantly inhibited this iNOS induction in a concentration-dependent manner (Fig. 4A) . A similar pattern was observed when the effect of styraxoside A was examined on LPS-induced COX-2 expression levels. However, styraxoside A did not affect the expression of the housekeeping gene b-actin. In general, these results are consistent with the profile of the inhibitory effects of styraxoside A on NO and PGE 2 release (Fig. 2) . Moreover, RT-PCR analysis showed that iNOS and COX-2 mRNA expressions correlated with their protein levels (Fig. 4B) .
Effects of Styraxoside A on LPS-Induced NF-k kB Activation To further investigate the mechanism of the styraxoside A-mediated inhibitions of iNOS, COX-2, TNF-a and IL-1b transcription, we focused on NF-kB, which is known to transactivate iNOS, COX-2, TNF-a and IL-1b. Electrophoretic mobility shift assay (EMSA) demonstrated that LPS-induced NF-kB-DNA binding activity in RAW 264.7 macrophages was significantly reduced by styraxoside A treatment in a concentration-dependent manner (Fig. 5) , and the extent of this reduction was similar in pattern to those of iNOS and COX-2 protein and iNOS, COX-2, TNF-a and IL-1b mRNAs.
DISCUSSION
During our continued searches for novel anti-inflammatory agents from natural products, we found that the methanol soluble fraction of the stem bark of S. japonica inhibited LPS-induced NO production in RAW 264.7 cells (data not shown). Although it has been previously reported that certain triterpenoids and lignans isolated from S. japonica extract have pharmacological effects, i.e., anti-complementary, 32) antioxidative 34, 35) and matrix metalloprotease (MMP)-1 inhibitory effects, 36, 37) its anti-inflammatory effects and the mechanisms involved have not been addressed.
In murine macrophage RAW 264.7 cells, LPS induces iNOS transcription and transduction, which is followed by NO production. Furthermore, LPS stimulation is known to induce IkB proteolysis and NF-kB nuclear translocation. 19) Therefore, RAW 264.7 cells provide us with an excellent model for drug screening and for subsequently evaluating potential inhibitors of the pathway leading to the induction of iNOS and the production of NO. The reactive free radical NO is a major macrophage-derived inflammatory mediator and has also been reported to be involved in the pathogeneses of inflammatory diseases. 7) In addition, a large amount of evidence suggests that prostaglandins (PGs) are involved in various pathophysiologic processes, including those of inflammation and carcinogenesis, and that the inducible isoform of cyclooxygenase (COX-2) is mainly responsible for the production of large amounts of these mediators.
11) Based on these findings, we screened for the effects of three recently discovered new compounds, norlignan (styraxlignolide A) and two terpenes (styraxosides A and B), and for the effects of two known compounds (egonol and masutakeside) isolated from the stem bark of S. japonica on LPS-induced pro-inflammatory molecules, including NO and PGE 2 . Styraxoside A was found to be the most potent inhibitor of these mediators among the compounds tested. Moreover, the inhibition of the LPS-stimulated expressions of these pro-inflammatory molecules by styraxoside A in RAW 264.7 cells was not attributed to cytotoxicity, as assessed by MTT assay.
To investigate the mode of action of styraxoside A as an anti-inflammatory, the effect of styraxoside A on LPS-induced response in murine macrophage cell line RAW 264.7 was investigated. It is well known that macrophages play a crucial role in both non-specific and acquired immune responses, and that macrophage activation by LPS leads to a functionally diverse series of responses, including the synthesis and the production of nitric oxide, prostanoids, and proinflammatory cytokines (TNF-a and IL-1b). We evaluated the effects of styraxoside A on the release and on the expression levels of several inflammatory mediators (iNOS, COX-2, TNF-a, and IL-1b) in LPS-activated macrophages. We found that LPS-induced NO, PGE 2 , TNF-a and IL-1b productions were inhibited by styraxoside A in a concentrationdependent manner. To further explore the possible mechanism of these inhibitions by styraxoside A, the expression levels of iNOS and COX-2 protein and mRNA were examined. Inhibitions of iNOS and COX-2 gene expressions were evidenced by reductions in their mRNA levels, and these occurred simultaneously and in a concentration-dependent manner (Fig. 3) , suggesting that the inhibition of NO and PGE 2 release might be attributable to the suppressions of iNOS and COX-2 mRNA transcription and thus their protein expressions.
It has been reported that cytokines, such as TNF-a and IL1b are pro-inflammatory in vitro and in vivo. 12, 13) In particular, the production of TNF-a is crucial for the synergistic induction of NO synthesis in IFN-g and/or LPS-stimulated macrophages. 38) TNF-a elicits a number of physiological effects including septic shock, inflammation, cachexia, and cytotoxicity. 39) In the present study, we found that styraxoside A also significantly inhibited TNF-a and IL-1b mRNA expressions (Fig. 4) .
NF-kB is known to play a critical role in the regulation of genes involved in cell survival, and to coordinate the expressions of proinflammatory enzymes including iNOS, COX-2, TNF-a and IL-1b 18) Therefore, we examined NF-kB-DNA binding activity to confirm that the inhibitions of the expressions of iNOS, COX-2, TNF-a and IL-1b are influenced by the NF-kB signaling pathway. Our results indicate that DNA binding activity was inhibited in a concentration-dependent manner by styraxoside A (Fig. 5) and these results corresponded with its inhibition of the expressions of iNOS, COX-2, TNF-a and IL-1b.
In conclusion, the results of the present study indicate that styraxoside A is a potent inhibitor of LPS-induced NO, 3A . Total RNA was prepared under conditions identical to those described for Fig. 3C and RT-PCR was performed to compared the mRNA levels of iNOS and COX-2. iNOS-specific sequences (807 bp) and COX-2-specific sequences (721 bp) were detected by agarose gel electrophoresis, as described in Materials and Methods. PCR of b-actin was performed to verify that the initial cDNA contents of samples were similar. The experiment was repeated three times and similar results were obtained. PGE 2 , TNF-a and IL-1b productions via gene expression by blocking NF-kB activation in RAW 264.7 macrophages. We conclude that styraxoside A appears to have the potential to prevent inflammatory diseases.
